Moderna’s Triple Helix Patent: A Clathrin mRNA Neural Lace Smoking Gun

This segment is part of the larger story about how Transhumanists are bringing about their Singularity utilizing 5G, Graphene Oxide, mRNA technology.. and your FEAR. I encourage you to take “GQD Particle: The Transhumanism Agenda” from the top. SPM

This little question was asked of me earlier in 2023. It’s about the 2013 mRNA patent who’s technology includes a triple helix. 

The claims out there by Dr. McCullough and other Front Line Doc’s say this triple helix is mutating our 2 strand DNA into 3 strands. 1

DARPA shell company Moderna has already thoroughly covered this question in their own press release, but I will look into it on my own.

Triple Helix DNA does exist and was discovered in 1995. They regulate genes. 2

Patent explains; “Described herein are compositions, methods, processes, kits and devices for the design, preparation, manufacture and/or formulation of modified mRNA (mRNA) molecules.”

That patent is for oncogenic proteins, they buckled the DNA then introduced their own enzymes to carry out replication.

The biologics are antibodies to treat disease, not cause cancer and they emphasize it is for Biologics used to treat disease. Antibodies specifically.

In the patent, it specifically states the problems with using biological delivery methods that can alter the DNA, this patent specifically states this is NOT such a protocol.

Now you know the angle, triple helix do exist, but they mostly regulate genes.  My guess is that in this patent it regulated the mRNA from the vaccine.  Hence why there was mRNA in every body cell in the first autopsy of a vaccinated person. 3

Are the genes from that mRNA in the DNA?  NOT LIKELY!

In theory they could have used the triple helix already in our DNA to push the manufacture of the mRNA they injected people with, an enzyme? Something that would encourage protein synthesis?

Part of SARSCoV2? The Clathrin nanobot? 4

My guess, it has to do with propagating the HEK293 cell line (human embryo kidney cell line). Vitaliano’s cell lines contain Luciferase genes and sv40 protein. 5

Moderna was using the HEK293 cell lines! They list all the cells that can be used and it’s there, HEK293!

Also contains Vitaliano’s Luciferase modified mRNA. 6

PEGylated Graphene Oxide in it too.

Sure, both the mRNA vaccine and Vitaliano’s used the HEK293 cell lines to develop their vaccine, but a lot of vaccines use these cell lines. There are THREE references in Moderna’s mRNA patent that specifically cite the “Clathrin”. Whether they used that technology or not to develop their mRNA would be proprietary information.

  • “Penheiter et al., Type II Transforming Growth Factor-13 Receptor Recycling Is Dependent upon the Clathrin Adaptor Protein Dab2, Molecular Biology of the Cell, vol. 21, 4009-4019, Nov. 15, 2010.
  • Mulkearns et al., FCHO2 organizes clathrin-coated structures and interacts with Dab2 for LDLR endocytosis, Molecular Biology of the Cell, 2012, pp. 1-28.
  • Teckchandani et al., The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin β1 endocytosis, Molecular Biology of the Cell, 2012, pp. 1-28.

They also use “lipid nanoparticles” in the formation of the mRNA. What does this mean? As a genetic material insert?

“The polynucleotide, primary construct, and mmRNA of the invention can be formulated using one or more liposomes, lipoplexes, or lipid nanoparticles. “

Furthermore, they refer to the Liposome design itself as being able to activate events such as “endocytosis” which is indeed the function of Clathrin:

 “Liposome design may include, but is not limited to, opsonins or ligands in order to improve the attachment of liposomes to unhealthy tissue or to activate events such as, but not limited to, endocytosis.”

Furthermore the authors of this patent specifically refer to the uptake of the mRNA via a receptor-mediated endocytosis (RME) similar in function to Clathrin RME. Here is the primary reference inserted in the patent document:

  • Lorenzi, J.C., et al., Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway. RNA Biology, vol. 8, No. 4, Jul. 1, 2011, pp. 252-258. 7

This confirms the Clathrin GQD neural interface technology was already being used in 2013. Vitaliano’s company is the holding company of ALL Clathrin patents. If you are using HEK293, and Clathrin and Luciferase, you are using Vitaliano’s GQD technology. 8

The whole planet has been infected by Clathrin using those MERS and SARS vectors we were earlier in 2021 so concerned about spreading. They isolated the mass contamination aspects of Ebola, MERS, SARS, … and removed the lethality? But added the Clathrin neuralace? The Clathrin neural lace can explain the whole thing. 9

For our protocols on deactivating the nano technology, see; “Deactivating the Graphene Quantum Dots & Decoupling your Brain from the Clathrin mRNA Neural Interface”, and remember, NO FEAR.

  1. Modified polynucleotides for the production of biologics and proteins associated with human disease:  Moderna, March 19 2013 ↩︎
  2. Triple-stranded DNA:  Wikipedia ↩︎
  3. The First Victim of the COVID-19 Vaccine: Patient dies from Antibody-Dependent Enhancement!:  CIN, June 19, 2021 ↩︎
  4. Graphene Quantum Dots are the Living Neural Interface “chip” for NWO AI:  CIN, January 25, 2023 ↩︎
  5. Collagen triple helix repeat-containing protein 1 HEK293 ↩︎
  6. Luciferase fuels mRNA Clathrin Nanobot & Transmits Quantum Information: CIN, January 31, 2023 ↩︎
  7. Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway:  NCBI, July 1 , 2011 ↩︎
  8. mRNA Developer, Obama “Brain Interface” Tzar, Directly Connected to Fauci & AI Transhumanist COVID Agenda:  CIN, January 29, 2023 ↩︎
  9. Gain-of-Function Experiments: The SARS-CoV-2/HIV-1 Story:  CIN, July 26, 2021 ↩︎

2 thoughts on “Moderna’s Triple Helix Patent: A Clathrin mRNA Neural Lace Smoking Gun

Leave a Reply